WO1997047323A3 - Chitosan drug delivery system - Google Patents

Chitosan drug delivery system Download PDF

Info

Publication number
WO1997047323A3
WO1997047323A3 PCT/US1997/010028 US9710028W WO9747323A3 WO 1997047323 A3 WO1997047323 A3 WO 1997047323A3 US 9710028 W US9710028 W US 9710028W WO 9747323 A3 WO9747323 A3 WO 9747323A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug delivery
chitosan
compositions
delivery system
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/010028
Other languages
French (fr)
Other versions
WO1997047323A2 (en
Inventor
Joseph S Podolski
Kuang T Hsu
Gurpreet Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repros Therapeutics Inc
Original Assignee
Zonagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zonagen Inc filed Critical Zonagen Inc
Priority to AU34814/97A priority Critical patent/AU3481497A/en
Priority to JP10501772A priority patent/JPH10513202A/en
Priority to EP97931091A priority patent/EP0843559A2/en
Publication of WO1997047323A2 publication Critical patent/WO1997047323A2/en
Publication of WO1997047323A3 publication Critical patent/WO1997047323A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates generally to a novel drug delivery composition. More specifically, the invention relates to a drug delivery compositions comprising an iron/chitosan particulate in combination with a desired drug, a chitosan-formulated drug compound, or chitosan/oil-surfactant in combination with a desired substance. The invention also contemplates methods for drug delivery involving the compositions as well as methods for producing the compositions.
PCT/US1997/010028 1996-06-11 1997-06-11 Chitosan drug delivery system Ceased WO1997047323A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU34814/97A AU3481497A (en) 1996-06-11 1997-06-11 Chitosan drug delivery system
JP10501772A JPH10513202A (en) 1996-06-11 1997-06-11 Chitosan drug delivery system
EP97931091A EP0843559A2 (en) 1996-06-11 1997-06-11 Chitosan drug delivery system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1954396P 1996-06-11 1996-06-11
US60/019,543 1996-06-11

Publications (2)

Publication Number Publication Date
WO1997047323A2 WO1997047323A2 (en) 1997-12-18
WO1997047323A3 true WO1997047323A3 (en) 1998-04-23

Family

ID=21793774

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/010028 Ceased WO1997047323A2 (en) 1996-06-11 1997-06-11 Chitosan drug delivery system

Country Status (6)

Country Link
EP (1) EP0843559A2 (en)
JP (1) JPH10513202A (en)
CN (1) CN1198100A (en)
AU (1) AU3481497A (en)
CA (1) CA2228251A1 (en)
WO (1) WO1997047323A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473247B2 (en) 1999-10-14 2009-01-06 Becton, Dickinson And Company Intradermal delivery of vaccines and gene therapeutic agents via microcannula

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19940794A1 (en) * 1999-08-27 2001-03-01 Lohmann Therapie Syst Lts Pharmaceutical preparation
FR2854072B1 (en) * 2003-04-23 2006-08-04 Centre Nat Rech Scient VECTOR FOR ORAL ADMINISTRATION
US7588774B2 (en) 2003-05-12 2009-09-15 Becton, Dickinson And Company Molecules enhancing dermal delivery of influenza vaccines
WO2007032018A1 (en) * 2005-09-15 2007-03-22 Council Of Scientific And Industrial Research pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES
EP1797870A1 (en) * 2005-12-14 2007-06-20 The Jordanian Pharmaceutical Manufacturing Co. Oral delivery of protein drugs using microemulsion
EP2042166A1 (en) * 2007-09-25 2009-04-01 The Jordanian Pharmaceutical Manufacturing Co. Nanocapsules for oral delivery of proteins
US9161901B2 (en) 2008-02-21 2015-10-20 University Of South Florida Nanoparticle targeted drug delivery to the lungs using extra-testicular Sertoli cells
US9872916B2 (en) 2012-04-06 2018-01-23 University of North Texas Office of Economic Development and Technology Transfer Facile method for making non-toxic biomedical compositions comprising hybrid metal-polymer microparticles
CN112999198A (en) * 2021-03-10 2021-06-22 中农宠物营养研究院(江苏)有限公司 Synbiotic microcapsule capable of resisting gastric acid and achieving intestinal tract targeted release based on chitosan-Fe coating and preparation method thereof

Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194497A2 (en) * 1985-03-14 1986-09-17 Etablissement Texcontor Chitosan derivatives in the form of coordinated complexes with ferrous ions
EP0200902A2 (en) * 1985-03-26 1986-11-12 Fujisawa Pharmaceutical Co., Ltd. Drug carrier and pharmaceutical preparation comprising it
JPS6281328A (en) * 1985-10-03 1987-04-14 Rooman Kogyo:Kk Long-acting drug preparation for oral administration
JPS63254102A (en) * 1985-03-14 1988-10-20 エタブリスメント・エクスコントール Ferrous ion ligand complex like chitosan derivatives
EP0392396A2 (en) * 1989-04-10 1990-10-17 Etablissement TEXCONTOR Complexes of iron or other metals with sulphonated derivatives of chitosan
EP0454383A1 (en) * 1990-04-23 1991-10-30 Aicello Chemical Co., Ltd. Large intestinal dissociative polypeptide series oral formulation
EP0466566A2 (en) * 1990-07-10 1992-01-15 Shin-Etsu Chemical Co., Ltd. Coated solid medicament form having releasebility in large intestine
JPH04247026A (en) * 1991-01-31 1992-09-03 Teikoku Seiyaku Co Ltd Oral agent disintegrating in lower part of digestive tract
JPH04327528A (en) * 1991-04-23 1992-11-17 Lion Corp Oral solid preparation
EP0526862A1 (en) * 1991-08-06 1993-02-10 VECTORPHARMA INTERNATIONAL S.p.A. Solid pharmaceutical compositions for oral administration with prolonged gastric residence
EP0576675A1 (en) * 1991-03-25 1994-01-05 Fujisawa Pharmaceutical Co., Ltd. Long-acting pharmaceutical preparation
JPH06256166A (en) * 1993-01-06 1994-09-13 ▲寛▼治 ▲高▼田 Pharmaceutical preparation for controlling release of medicine
EP0619322A2 (en) * 1993-04-07 1994-10-12 Pfizer Inc. Prolonged delivery of peptides
EP0622077A1 (en) * 1993-04-22 1994-11-02 Takeda Chemical Industries, Ltd. Angiotensin II antagonists as a prophylactic or therapeutic drug for renal diseases
JPH07258087A (en) * 1994-03-25 1995-10-09 Toko Yakuhin Kogyo Kk Allopurinol mouthwash
EP0687466A1 (en) * 1994-06-16 1995-12-20 Tapuach Natural Technologies (1993) Ltd. Homeopathic formulations
EP0705607A2 (en) * 1994-10-07 1996-04-10 Takeda Chemical Industries, Ltd. Condensed seven- or eight-membered heterocyclic compounds useful as antihypertriglyceridemic agents
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63254102A (en) * 1985-03-14 1988-10-20 エタブリスメント・エクスコントール Ferrous ion ligand complex like chitosan derivatives
EP0194497A2 (en) * 1985-03-14 1986-09-17 Etablissement Texcontor Chitosan derivatives in the form of coordinated complexes with ferrous ions
EP0200902A2 (en) * 1985-03-26 1986-11-12 Fujisawa Pharmaceutical Co., Ltd. Drug carrier and pharmaceutical preparation comprising it
JPS6281328A (en) * 1985-10-03 1987-04-14 Rooman Kogyo:Kk Long-acting drug preparation for oral administration
EP0392396A2 (en) * 1989-04-10 1990-10-17 Etablissement TEXCONTOR Complexes of iron or other metals with sulphonated derivatives of chitosan
EP0454383A1 (en) * 1990-04-23 1991-10-30 Aicello Chemical Co., Ltd. Large intestinal dissociative polypeptide series oral formulation
EP0466566A2 (en) * 1990-07-10 1992-01-15 Shin-Etsu Chemical Co., Ltd. Coated solid medicament form having releasebility in large intestine
JPH04247026A (en) * 1991-01-31 1992-09-03 Teikoku Seiyaku Co Ltd Oral agent disintegrating in lower part of digestive tract
EP0576675A1 (en) * 1991-03-25 1994-01-05 Fujisawa Pharmaceutical Co., Ltd. Long-acting pharmaceutical preparation
JPH04327528A (en) * 1991-04-23 1992-11-17 Lion Corp Oral solid preparation
EP0526862A1 (en) * 1991-08-06 1993-02-10 VECTORPHARMA INTERNATIONAL S.p.A. Solid pharmaceutical compositions for oral administration with prolonged gastric residence
JPH06256166A (en) * 1993-01-06 1994-09-13 ▲寛▼治 ▲高▼田 Pharmaceutical preparation for controlling release of medicine
EP0619322A2 (en) * 1993-04-07 1994-10-12 Pfizer Inc. Prolonged delivery of peptides
EP0622077A1 (en) * 1993-04-22 1994-11-02 Takeda Chemical Industries, Ltd. Angiotensin II antagonists as a prophylactic or therapeutic drug for renal diseases
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
JPH07258087A (en) * 1994-03-25 1995-10-09 Toko Yakuhin Kogyo Kk Allopurinol mouthwash
EP0687466A1 (en) * 1994-06-16 1995-12-20 Tapuach Natural Technologies (1993) Ltd. Homeopathic formulations
EP0705607A2 (en) * 1994-10-07 1996-04-10 Takeda Chemical Industries, Ltd. Condensed seven- or eight-membered heterocyclic compounds useful as antihypertriglyceridemic agents

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
CHANDY T. ET AL.: "Biodegradable chitosan matrix for the controlled release of steroids", BIOMATER. ARTIF. CELLS IMMOBILIZATION BIOTECHNOL., vol. 19, no. 4, 1991, USA, pages 745 - 760, XP002055071 *
DATABASE WPI Section Ch Week 8720, Derwent World Patents Index; Class A96, AN 87-140921, XP002055074 *
DATABASE WPI Section Ch Week 8848, Derwent World Patents Index; Class A96, AN 88-341892, XP002048975 *
DATABASE WPI Section Ch Week 9242, Derwent World Patents Index; Class A96, AN 92-343803, XP002055076 *
DATABASE WPI Section Ch Week 9252, Derwent World Patents Index; Class B07, AN 92-430051, XP002055077 *
DATABASE WPI Section Ch Week 9441, Derwent World Patents Index; Class A96, AN 94-329906, XP002055075 *
DATABASE WPI Section Ch Week 9549, Derwent World Patents Index; Class A96, AN 95-379983, XP002055073 *
GEARY R.S. ET AL.: "Vancomycin and insulin used as models for oral delivery of peptides", J.CONTROL.RELEASE, vol. 23, no. 1, January 1993 (1993-01-01), NETHERLANDS, pages 65 - 74, XP000332069 *
HARI,P.R. ET AL.: "Chitosan/calcium-alginate beads for oral delivery of insulin", J.APPL.POLYM.SCI., vol. 59, no. 11, 1996, pages 1795 - 1801, XP002055072 *
HIROFUMI TAKEUCHI ET AL.: "Enteral absorption in rats from mucoadhesive chitosan-coated liposomes", PHARM. RES., vol. 13, no. 6, June 1996 (1996-06-01), USA, pages 896 - 901, XP002055070 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473247B2 (en) 1999-10-14 2009-01-06 Becton, Dickinson And Company Intradermal delivery of vaccines and gene therapeutic agents via microcannula

Also Published As

Publication number Publication date
WO1997047323A2 (en) 1997-12-18
CA2228251A1 (en) 1997-12-18
CN1198100A (en) 1998-11-04
AU3481497A (en) 1998-01-07
EP0843559A2 (en) 1998-05-27
JPH10513202A (en) 1998-12-15

Similar Documents

Publication Publication Date Title
AU1621799A (en) Fungicidal compositions and methods, and compounds and methods for the preparation thereof
AU4048299A (en) Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
ZA968850B (en) Phenylacetic acid derivatives, processes and intermediate for their preparation, and compositions comprising them.
AU2002214260A1 (en) Granular composite additive for polyolefin, process for producing the same, and polyolefin composition containing the same
AU7808198A (en) Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
AU9744298A (en) Substituted tetrahydronaphthaline and analogous compounds
ZA200201511B (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents.
AU2001235695A1 (en) Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof
IE882594L (en) Water-hardening polymer preparation
ZA99355B (en) Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them.
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU4278593A (en) Antimicrobial compositions, process for preparing the same and use
AU1148099A (en) Powder varnish composition, method for producing and the use thereof
AU8414098A (en) Noscapine derivatives, useful as anticancer agents
EP0667374A3 (en) Bitumens modified by polymeric compositions.
HUP0001058A3 (en) 5-hydroxymethyl-2-aminotetralins as cardiovascular agents, process for producing the same and pharmaceutical compositions containing them
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
WO1999012945A3 (en) Hydrophobic glycosylamine derivatives, compositions, and methods for use
AU8127898A (en) Pyridyltriazole compounds, processes for producing the same and agricultural andhorticultural germicides
IL139863A0 (en) 3,4-diphenyl bicyclo [4.3.0] nonyl derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
AU5419699A (en) Methoximinophenylacetic acid amides
HRP20000542B1 (en) Fungicides

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97190999.7

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA CN JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref document number: 2228251

Country of ref document: CA

Ref document number: 2228251

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 1998 501772

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1997931091

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA CN JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWP Wipo information: published in national office

Ref document number: 1997931091

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997931091

Country of ref document: EP